Bristol Myers Squibb

Pharmaceuticals
BMY
$ 51 0.81
Share price
$ 103 bn
Market Cap
$ 132 bn
Enterprise Value

Carbon footprint

2.1 Ton
GHG emissions per $ 1 mln investment
0.06x the weighted average for S&P 500
FY2020
How is this calculated?
-2.1%
YOY change in GHG emissions
Weaker than the -11% weighted average for S&P 500
FY2020 vs. previous year

Primary Climate Goal

This company has not set a company-wide target for an absolute reduction in GHG emissions yet

GHG emissions and Carbon intensity

Bristol Myers Squibb's GHG emissions (market-based) (Kt of CO2e)
Bristol Myers Squibb's Carbon intensity (Tons per 1 USDm)

Bristol Myers Squibb's carbon footprint

Bristol Myers Squibb reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2020 at 278 Kt (-6 /-2.1% y-o-y). Also positively, carbon intensity dropped to 6.5 t (-4.4 /-40.4% y-o-y).

Bristol Myers Squibb's Scope 3 emissions tumbled to 12 Kt (-44 /-78.7% y-o-y). This is a higher rate of decline than over the period since 4Q'16 (-31.1% CAGR).

The company has not set a company-wide target for an absolute reduction in GHG emissions yet.

Company environmental metrics

Show more...